Expanding the molecular spectrum of tenosynovial giant cell tumors

BACKGROUND: While great advances in clinical and pathological description of tenosynovial giant cell tumors (TGCT) have been made, TGCT molecular heterogeneity represents an ongoing challenge. The canonical oncogenic fusion CSF1::COL6A3 is not systematically observed, suggesting that other oncogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauduchon, Thibault, Vanacker, Helene, Pissaloux, Daniel, Cassier, Philippe, Dufresne, Armelle, Karanian, Marie, Meurgey, Alexandra, Bouhamama, Amine, Gouin, François, Ray-Coquard, Isabelle, Blay, Jean-Yves, Tirode, Franck, Brahmi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691341/
https://www.ncbi.nlm.nih.gov/pubmed/36439507
http://dx.doi.org/10.3389/fonc.2022.1012527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691341/
https://www.ncbi.nlm.nih.gov/pubmed/36439507
http://dx.doi.org/10.3389/fonc.2022.1012527

Ejemplares similares